RSNA 2003 

Abstract Archives of the RSNA, 2003


509-p

Dopamine Transporter Density of the Basal Ganglia Assessed with I-123 IPT SPECT before and after Methylphenidate Treatment in Children with Attention Deficit Hyperactivity Disorder

Scientific Posters

Presented on November 30, 2003
Presented as part of B16: Pediatric Pediatric Neuroradiology I

Participants

Won Gee Ryu MD, PRESENTER: Nothing to Disclose

Abstract: HTML Purpose: ADHD has been known as psychiatric disorder in childhood associated with dopamine dysregulation. The symptoms of ADHD can be treated with methylphenidate, a potent blocker of the dopamine transporter (DAT). In present study, we investigated DAT density using I-123 N-(3-iodopropen-2-yl)-2beta-carbomethoxy-3beta-(4-chlorophenyl)tropane (I-123 IPT) SPECT in children with ADHD before and after treatment with methylphenidate. Methods and Materials: Seven drug-naive children with ADHD and eight normal children were included in the study and performed SPECT 2 hours after an intravenous administration of I-123IPT. All children with ADHD reperformed I-123IPT SPECT after treatment with methylphenidate (0.7mg/kg/d) during about 8 weeks. SPECT data reconstructed for the assessment of specific/nonspecific DAT binding ratio of the basal ganglia were compared between before and after treatment methylphenidate. We investigated correlation between the change of ADHD symptom severity assessed with ADHD rating scale-IV and specific/nonspecific DAT binding ratio of basal ganglia. Results: Children with ADHD had a significantly greater increase of specific/nonspecific DAT binding ratio of right basal ganglia than normal children (Right: z = 2.085, p = 0.037 ; Left: z = 1.506, p = 0.132). Under treatment with methylphenidate in all children with ADHD, specific/nonspecific DAT binding ratio of both basal ganglia decreased significantly greater than before treatment with methylphenidate (Right: t = 3.239, p = 0.018 ; Left: t = 3.133, p = 0.020). However, no significant correlation between the change of ADHD symptom severity scores and specific/nonspecific DAT binding ratio of the basal ganglia were found. Conclusion: The data of this study using methylphenidate in children with ADHD support the complex dysregulation of the dopaminergic neurotransmitter system in children with ADHD.       Questions about this event email: ryuyh@yumc.yonsei.ac.kr

Cite This Abstract

Ryu MD, W, Dopamine Transporter Density of the Basal Ganglia Assessed with I-123 IPT SPECT before and after Methylphenidate Treatment in Children with Attention Deficit Hyperactivity Disorder.  Radiological Society of North America 2003 Scientific Assembly and Annual Meeting, November 30 - December 5, 2003 ,Chicago IL. http://archive.rsna.org/2003/3105703.html